Diapharma announces partnership with HemaCore

Posted: February 13, 2019

HemaCore was founded in 2010 as a biotech company focused on developing, manufacturing and implementing new technology for hemostasis – thrombodynamics.

Thrombodynamics® assay – an innovative coagulation test for risk assessment of blood coagulation disorders – bleedings and thrombosis.

HemaCore helps provide clear and reliable estimation of subjects coagulation state, thus giving an ability to prevent thrombotic or bleeding complications.

HemaCore products

  • Thrombodynamics® Analyzer (T2F)
  • Thrombodynamics® Analyzer (T2T)
  • Thrombodynamics® TDX Kit (TDX-10)
  • Thrombodynamics® PLS Kit (PLS-10)

HemaCore Company Page